Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine for prevention of SARS-CoV-2 infection and reduction of COVID-19 severity during pregnancy
2020-001587-29Phase 4Completed
- Sponsor
- Barcelona Institute for Global Health
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of hydroxychloroquine in coronavirus disease 2019 (COVID-19), sponsored by Barcelona Institute for Global Health. Primary endpoint: Mean reduction in viral load at day 14. Started Apr 2020; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001587-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001587-29.